Article
The voltage-gated calcium channel blocker lomerizine is neuroprotective in motor neurons expressing mutant SOD1, but not TDP-43.
Journal of neurochemistry - 1 Aug 2014
Tran Luan T, Gentil Benoit J, Sullivan Kathleen E, Durham Heather D
Abstract excerpt
Excitotoxicity and disruption of Ca(2+) homeostasis have been implicated in amyotrophic lateral sclerosis (ALS) and limiting Ca(2+) entry is protective in models of ALS caused by mutation of SOD1. Lomerizine, an antagonist of L- and T-type voltage-gated calcium channels and transient receptor potential channel 5 transient receptor potential channels, is well tolerated clinically, making it a potential therapeutic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
